2019 Innovations in Cancer Treatment and Care Conference
The Cancer Institute NSW is pleased to announce the 8th annual Innovations in Cancer Treatment and Care Conference. This conference brings together clinicians, health workers, researchers and people affected by cancer to foster innovation and continuous improvement across the NSW cancer health system.
Jump to:
When: Thursday 26 September 2019
Time: 8.30am – 6pm | Registration open at 8.30am | Networking 5pm to 6pm
Where: Sofitel Sydney Wentworth, 61-101 Phillip Street, Sydney
The 2019 conference addressed equity of outcome in cancer control, explored through the following themes:
- Priority populations (e.g gender, Culturally and Linguistically Diverse (CALD), Aboriginal and Torres Strait Islander communities and rural/remote communities)
- Technology to improve equity (e.g telehealth)
- Cultural safety
- Tools to support equity (e.g transport, finance)
- Health literacy
- Collaborative frameworks
Keynote speaker
Professor Diana Sarfati (MBChB, MPH, PhD, FNZCPHM)
Professor Diana Sarfati (MBChB, MPH, PhD, FNZCPHM) is a public health physician, cancer epidemiologist and health services researcher. She is Head of the Department of Public Health and the Director of the Cancer and Chronic Conditions (C3) Research Group at University of Otago, Wellington. She is currently a member of the New Zealand National Cancer Leadership Board (NZ), the Advisory Committee to International Agency for Research on Cancer’s (IARC) Pacific cancer hub, the Academic Advisory Committee to IARC on the International Cancer Benchmarking Project, and she is currently leading a Lancet Oncology series on cancer control in small island developing states.
Professor Sarfati has led a large body of research relating to ethnic disparities in cancer outcomes in New Zealand. This work has resulted in the identification of key patient and health system factors that influence cancer survival. It has been used extensively by health policy makers, clinicians and other researchers to develop policies and practices that aim to reduce inequities in cancer outcomes.
She also has research interests in the inter-relationships between cancer and comorbidity, screening and multimorbidity.
Professor Sarfati is a past member of the National Ethics Advisory Committee, National Screening Advisory Group, the Bowel Cancer Screening Taskforce, the National Bowel Cancer Working Group, the Board of the Cancer Society (Wellington Division), the Cancer Society Medical and Scientific Assessment Committee (Wellington) and the National Cancer Society Health Promotion Committee.
- Read more about how Professor Sarfati is committed to making sure cancer systems treat everybody fairly
Conference gallery
See the 2019 highlights and discussion captured through #CancerInnovations on Twitter.
Conference program
Thursday 26 September 2019
7.30am – 8.30am |
Early Morning Speed Mentoring* *This is a closed session |
8.30am – 9.00am |
Registration |
Room: |
Wentworth Ballroom |
9.00am – 11.00am |
PLENARY SESSION 1 |
9.00am – 9.30am |
Hosted by Julie McCrossin AM |
9.30am – 10.00am |
Keynote address Cancer inequalities and what we can do about them |
10.00am – 10.10am |
Questions and answers facilitated by Julie McCrossin AM |
10.10am – 11.00am |
PANEL DISCUSSION |
|
How do we achieve equity of outcomes in cancer control? Prof Diana Sarfati, Head of Department, Department of Public Health and Director of the Cancer and Chronic Conditions Research Group, Otago University |
11.00am – 11.30am |
MORNING TEA |
11.30am – 1.00pm |
MORNING CONCURRENT SESSIONS |
|
Cultural safety |
11.30am – 11.45am |
Cancer and palliative care nurses’ experiences of caring for Chinese migrants with cancer pain |
11.45am – 12.00pm |
Colorectal cancer diagnosis and treatment: Impact of a patient’s CALD status |
12.00pm – 12.15pm |
Cultural beliefs affecting access to cancer information for Arabic, Chinese and Vietnamese-speaking people |
12.15pm – 12.30pm |
Improving cultural safety in both campuses of the Mid North Coast Cancer Institute |
12.30pm – 12.45pm |
Training our oncology health care professionals to communicate more effectively with migrants |
12.45pm – 1.00pm |
Pain management experiences and needs of Chinese migrant cancer patients: A focus group study |
|
Priority populations |
11.30am – 11.45am |
Reaching out remote chemotherapy from Dubbo |
11.45am – 12.00pm |
Breast density and breast cancer screening in Indigenous women in the Northern Territory |
12.00pm – 12.15pm |
Bowel cancer campaign targeting Arabic speaking communities in Victoria |
12.15pm – 12.30pm |
Influencing national application of the Optimal Care Pathway for Aboriginal and Torres Strait Islander people with cancer |
12.30pm – 12.45pm |
Cancer Outcomes improving in Australia, but not for First Nations people: an integrative review |
12.45pm – 1.00pm |
Thinking out loud: Conversations, collaborations and informal systems reform to combat insufficient rural infrastructure |
1.00pm – 2.00pm |
LUNCH |
1.30pm – 2.00pm |
Poster lighting talks Presenters: RT underutilisation in prostate cancer patients on overall survival and local control, NSW Strengthening multidisciplinary team performance in cancer services: Three years’ experience Investigating the impact of chemotherapy-induced peripheral neuropathy in cancer survivors Are we ready for virtual multidisciplinary team care? Radiotherapy underutilisation and its impact on local control and survival in NSW, Australia Does socioeconomic disadvantage affect radiotherapy utilisation in rectal cancer? Measuring quality of lung cancer care |
1.30pm – 1.55pm |
Experiential Session: Matter over mind |
2.00pm – 3.30pm |
AFTERNOON CONCURRENT SESSIONS |
|
Collaborative frameworks |
2.00pm – 2.15pm |
Breastscreen NSW Greater Western Aboriginal engagement project: Phase 2 – re-engagement |
2.15pm – 2.30pm |
Cancer Institute NSW multicultural data app |
2.30pm – 2.45pm |
It takes a village: Collaboration can achieve return to life and employment in the community |
2.45pm – 3.00pm |
Equity in practice – the importance of community engagement |
3.00pm – 3.15pm |
Promoting participation in the National Cervical Screening Program to Aboriginal and Torres Strait Islander women |
3.15pm – 3.30pm |
Using national linked data to report cancer outcomes |
3.30pm – 4.00pm |
AFTERNOON TEA |
4.00pm – 5.00pm |
PLENARY SESSION 2 |
4.00pm – 4.30pm |
The impact of social determinants of health on cancer incidence and access to care |
4.30pm – 4.50pm |
Questions and answers facilitated by Julie McCrossin AM |
4.50pm – 5pm |
Presentations, Judging and Closing |
|
First-time oral presentation at Innovations Conference Closing remarks |
5pm - 6pm |
NETWORKING FUNCTION (drinks and canapés) |
6pm |
Conference concludes |
Conference Posters
The following posters will be displayed during the conference:
- Barriers and facilitators to establishing radiotherapy services in low-and-middle-income countries: A qualitative study
- Trials & Tribulations: Working Towards Sustainable Solutions for Investigator Driven Clinical Trials
- Caring for patients’ skin during radiotherapy before immediate autologous breast reconstruction – a team based approach
- Strengthening Multidisciplinary Team Performance in Cancer Services; Three Years’ Experience
- Exercise Therapy to improve Quality of Life and Fatigue post Autologous Bone Marrow Transplantation
- Investigating the impact of chemotherapy induced peripheral neuropathy in cancer survivors
- Health professionals’ views on barriers and facilitators to uptake of online psychological therapy
- The power of collaboration in rural and remote areas
- RT underutilization in prostate cancer patients and its effect on overall survival & local control, NSW
- Smarter, Safer Vital Signs Monitoring
- Unmet need sexual health South Western Sydney Local Health District Cancer services
- eChemotherapy Advisory Group (eCAG): Safe , Collaborative & Quality Governance for eChemo in Western Sydney Local Health District
- Does socio-economic disadvantage affect radiotherapy utilisation in rectal cancer?
- Patient Focus Groups held in languages other than English – our journey so far
- Biobank recruitment in head and neck cancer patients: CALD considerations
- Patterns of care and variation for women with ovarian cancer in NSW
- Our Health, Our Cancer Journey
- Transforming Healthcare through Outcome Measures for Rectal Cancer
- Are we ready for virtual multidisciplinary team care?
- Translation of Lung Multidisciplinary team meeting (MDM) Recommendations into Clinical Practice
- Enriching Health Science Alliance Biobank with clinical data from New South Wales Cancer Registry
- Community Called to Action: Strategies and successes in engaging consumer advocates in cancer research programs
- Radiotherapy underutilisation and its impact on local control and survival in NSW
- Measuring Quality of Lung Cancer Care
- Equity with Hybrid Systems by focusing on HIGH safety and quality to BRIDGE training gaps
- External Peer Review of the Western NSW Lung Cancer Service – unique Australian experience
- Accelerated deployment of scalable secure messaging between South Western Sydney Local Health District Cancer Services/Haematology and GPs/Specialists
- The cost of radiotherapy for 5-year local control and overall survival benefit